| Literature DB >> 26482802 |
Wissam H Faour1, Mohamed Mroueh2, Costatantine F Daher3, Rasha Y Elbayaa4,5, Hanan M Ragab4, Asser I Ghoneim6,7, Ahmed I El-Mallah8, Hayam M A Ashour4.
Abstract
Four series of new bipyrazoles comprising the N-phenylpyrazole scaffold linked to polysubstituted pyrazoles or to antipyrine moiety through different amide linkages were synthesized. The synthesized compounds were evaluated for their anti-inflammatory and analgesic activities. In vitro COX-1/COX-2 inhibition study revealed that compound 16b possessed the lowest IC50 value against both COX-1 and COX-2. Moreover, the effect of the most promising compounds on inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX-2) protein expression in lipopolysaccharide (LPS)-activated rat monocytes was also investigated. The results revealed that some of the synthesized compounds showed anti-inflammatory and/or analgesic activity with less ulcerogenic potential than the reference drug diclofenac sodium and are well tolerated by experimental animals. Moreover, they significantly inhibited iNOS and COX-2 protein expression induced by LPS stimulation. Compounds 16b and 18 were proved to display anti-inflammatory activity superior to diclofenac sodium and analgesic activity equivalent to it with minimal ulcerogenic potential.Entities:
Keywords: Anti-inflammatory; COX-2; analgesic; iNOS
Mesh:
Substances:
Year: 2015 PMID: 26482802 DOI: 10.3109/14756366.2015.1094469
Source DB: PubMed Journal: J Enzyme Inhib Med Chem ISSN: 1475-6366 Impact factor: 5.051